BMJ Group: Most Obesity Drugs Do Not Improve Quality of Life or Heart Health
July 09, 2026
July 09, 2026
LONDON, England, July 9 (TNSjou) -- BMJ Group issued the following news release about The BMJ:
* * *
Most obesity drugs do not improve quality of life or heart health
Treatment decisions should be individualised, balancing expected benefits, harms, treatment burden, costs, availability, and patient preferences, say researchers
-
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully impr . . .
* * *
Most obesity drugs do not improve quality of life or heart health
Treatment decisions should be individualised, balancing expected benefits, harms, treatment burden, costs, availability, and patient preferences, say researchers
-
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully impr . . .